On the role of cannabinoid CB1and μ-opioid receptors in motor impulsivity

Frontiers in Pharmacology

Volumn 3 JUN, Issue , 2012, Pages

  Wiskerke, Joost ^a   van Mourik, Yvar ^a   Schetters, Dustin ^a   Schoffelmeer, Anton N M ^a   Pattij, Tommy ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 choice serial reaction time task; Endocannabinoid system; Endogenous opioid system; Inhibitory response control; Mesocortical dopamine system; Mesolimbic dopamine system; Nicotine; Rat

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; MU OPIATE RECEPTOR; NALOXONE; NEUROTRANSMITTER; NICOTINE; OPIATE; RIMONABANT; SEROTONIN 2C RECEPTOR; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG MECHANISM; LIMBIC CORTEX; MALE; MOTOR ACTIVITY; NERVE CELL MEMBRANE POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PHARMACOLOGICAL STIMULATION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

EID: 84866175774     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00108     Document Type: Article

References (88)

1. Baarendse, P. J., and Vanderschuren, L. J. (2012). Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl.) 219,313-326.
2. Berrendero, F., Mendizabal, V., Robledo, P., Galeote, L., Bilkei-Gorzo, A., Zimmer, A., and Maldonado, R. (2005). Nicotineinduced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 25,1103-1112.
3. Berrendero, F., Robledo, P., Trigo, J. M., Martin-Garcia, E., and Maldonado, R. (2010). Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav. Rev. 35, 220-231.
4. Bickel, W. K., Odum, A. L., and Madden, G. J. (1999). Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl.) 146, 447-454.
5. Blondel, A., Sanger, D. J., and Moser, P. C. (2000). Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology (Berl.) 149, 293-305.
6. Broos, N., Schmaal, L., Wiskerke, J., Kostelijk, L., Lam, T., Stoop, N., Weierink, L., Ham, J., de Geus, E. J., Schoffelmeer, A. N., van den, B. W., Veltman, D. J., De Vries, T. J., Pattij, T., and Goudriaan, A. E. (2012). The relationship between impulsive choice and impulsive action: a cross-species translational study. PLoS ONE 7, e36781. doi:10.1371/journal.pone.0036781
7. Buckholtz, J. W., Treadway, M. T., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Shelby, E. S., Smith, C. E., Kessler, R. M., andZald, D. H. (2010). Dopaminergic network differences in human impulsivity. Science 329, 532.
8. Centonze, D., Bari, M., Di Michele, B., Rossi, S., Gasperi, V., Pasini, A., Battista, N., Bernardi, G., Curatolo,P., andMacCarrone, M. (2009). Altered anandamide degradation in attentiondeficit/hyperactivity disorder. Neurology 72, 1526-1527.
9. Cole, B. J., and Robbins, T. W. (1987). Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergicnoradrenergic interactions. Psychopharmacology (Berl.) 91,458-466.
10. Cole, B. J., and Robbins, T. W. (1989). Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav. Brain Res. 33, 165-179.
11. Counotte, D. S., Goriounova, N. A., Li, K. W., Loos, M., Van der Schors, R. C., Schetters, D., Schoffelmeer, A. N., Smit, A. B., Mansvelder, H. D., Pattij, T., and Spijker, S. (2011). Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence. Nat. Neurosci. 14,417-419.
12. Counotte, D. S., Spijker, S., Van de Burgwal, L. H., Hogenboom, F., Schoffelmeer, A. N., De Vries, T. J., Smit, A.B., and Pattij, T. (2009). Longlasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology 34, 299-306.
13. Dalley, J. W., Everitt, B. J., and Robbins, T. W. (2011). Impulsivity, compulsivity, and topdown cognitive control. Neuron 69, 680-694.
14. Dalley, J. W., Fryer, T. D., Brichard, L., Robinson, E. S., Theobald, D. E., Laane, K., Pena, Y., Murphy, E. R., Shah, Y., Probst, K., Abakumova, I., Aigbirhio, E I., Richards, H. K., Hong, Y., Baron, J. C., Everitt, B. J., and Robbins, T. W. (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315, 1267-1270.
15. Dalley, J. W., Theobald, D. E., Berry, D., Milstein, J. A., Laane, K., Everitt, B.J., and Robbins, T. W. (2005). Cognitive sequelae of intravenous amphetamine selfadministration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology 30, 525-537.
16. Dalley, J. W., Theobald, D. E., Eagle, D.M., Passetti, F., and Robbins, T. W. (2002a). Deficits in impulse control associated with tonicallyelevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26, 716-728.
17. Dalley, J. W., Theobald, D. E., Pereira, E.A., Li, P. M., and Robbins, T. W. (2002b). Specific abnormalities in serotonin release in the prefrontal cortex of isolationreared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity. Psychopharmacology (Berl.) 164, 329-340.
18. De Bruin, N. M., Lange, J. H., Kruse, C.G., Herremans, A. H., Schoffelmeer, A. N., van Drimmelen, M., and De Vries, T. J. (2011). SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats. Behav. Brain Res. 217,408-415.
19. Di Chiara, G., and Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85, 5274-5278.
20. Diergaarde, L., Pattij, T., Poortvliet, I., Hogenboom, F., de Vries, W., Schoffelmeer, A. N., and De Vries, T. J. (2008). Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol. Psychiatry 63, 301-308.
21. Diergaarde, L., van Mourik, Y., Pattij, T., Schoffelmeer, A. N., and De Vries, T. J. (2011). Poor impulse control predicts inelastic demand for nicotine but not alcohol in rats. Addict. Biol. 17, 576-587.
22. Doran, N., Spring, B., and McChargue, D. (2007). Effect of impulsivity on craving and behavioral reactivity to smoking cues. Psychopharmacology (Berl.) 194,279-288.
23. Eguchi, M. (2004). Recent advances in selective opioid receptor agonists and antagonists. Med. Res. Rev. 24, 182-212.
24. Ehlers, C. L., Slutske, W. S., Lind, P. A., and Wilhelmsen, K. C. (2007). Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Twin Res. Hum. Genet. 10, 805-811.
25. El Khoury, M. A., Gorgievski, V., Moutsimilli, L., Giros, B., and Tzavara, E. T. (2012). Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies. Prog. Neuropsychopharmacol Biol. Psychiatry. doi: 10.1016/j.pnpbp.2011.12.005.
26. Elsworth, J. D., Taylor, J. R., Berger, P., and Roth, R. H. (1993). Cocainesensitive and -insensitive dopamine uptake in prefrontal cortex, nucleus accumbens and striatum. Neurochem. Int. 23, 61-69.
27. Evenden,J.L. (1999).Varieties of impulsivity. Psychopharmacology (Berl.) 146, 348-361.
28. Fallon, J. H., and Moore, R. Y. (1978). Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180, 545-580.
29. Fletcher, P. J., Rizos, Z., Noble, K., and Higgins, G. A. (2011). Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade. Neuropharmacology 61, 468-477.
30. Freed, C., Revay, R., Vaughan, R. A., Kriek, E., Grant, S., Uhl, G. R., and Kuhar, M. J. (1995). Dopamine transporter immunoreactivity in rat brain.J. Comp. Neurol. 359,340-349.
31. Goldstein, A., and Naidu, A. (1989). Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36, 265-272.
32. Goto, Y., and Grace, A. A. (2007). The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int. Rev. Neurobiol. 78,41-68.
33. Grottick, A. J., and Higgins, G. A. (2000). Effect of subtype selective nicotinic compounds on attention as assessed by the fivechoice serial reaction time task. Behav. Brain Res. 117, 197-208.
34. Hadjiconstantinou, M., and Neff, N. H. (2011). Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology 60,1209-1220.
35. Higgins, G. A., Silenieks, L. B., Rossmann, A., Rizos, Z., Noble, K., Soko, A. D., and Fletcher, P. J. (2012). The 5-HT(2C) receptor agonist lorcaserin reduces nicotine selfadministration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology 37, 1177-1191.
36. Hooks, M. S., Jones, D. N., Justice, Jr.J. B.., and Holtzman, S. G. (1992). Naloxone reduces amphetamineinduced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 42, 765-770.
37. Hurd, Y. L., and Herkenham, M. (1992). Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res. Mol. Brain Res. 16, 97-104.
38. Jentsch, J. D., and Taylor, J. R. (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by rewardrelated stimuli. Psychopharmacology (Berl.) 146, 373-390.
39. Kieres, A. K., Hausknecht, K. A., Farrar, A. M., Acheson, A., De Wit, H., and Richards, J.B. (2004). Effects of morphine and naltrexone on impulsive decision making in rats. Psychopharmacology (Berl.) 173,167-174.
40. Kleijn, J., Wiskerke, J., Cremers, T. I., Schoffelmeer, A. N., Westerink, B. H., and Pattij, T. (2012). Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation. Neurochem. Int. 60,791-798.
41. Leggio, G. M., Cathala, A., Neny, M., Rouge-Pont, F., Drago, F., Piazza, P. V., and Spampinato, U. (2009). In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. J. Neurochem. 111, 614-623.
42. Liu, F., Grauer, S., Kelley, C., Navarra, R., Graf, R., Zhang, G., Atkinson, P. J., Popiolek, M., Wantuch, C., Khawaja, X., Smith, D., Olsen, M., Kouranova, E., Lai, M., Pruthi, F., Pulicicchio, C., Day, M., Gilbert, A., Pausch, M. H., Brandon, N. J., Beyer, C. E., Comery, T. A., Logue, S., Rosenzweig-Lipson, S., and Marquis, K. L. (2008). ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychoticlike and procognitive activities. J. Pharmacol. Exp. Ther. 327, 827-839.
43. Love, T. M., Stohler, C. S., and Zubieta, J. K. (2009). Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch. Gen. Psychiatry 66, 1124-1134.
44. Maisonneuve, I. M., and Glick, S. D. (1999). (+/-)Cyclazocine blocks the dopamine response to nicotine. Neuroreport 10, 693-696.
45. Marshall, D. L., Redfern, P. H., and Wonnacott, S. (1997). Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotinetreated rats. J. Neurochem. 68, 1511-1519.
46. McGinty, J. E. (1999). Regulation of neurotransmitter interactions in the ventral striatum. Ann. N. Y. Acad. Sci. 877, 129-139.
47. Mitchell, J. M., Tavares, V C, Fields, H. L., D'Esposito, M., and Boettiger, C. A. (2007). Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls. Neuropsychopharmacology 32, 439-449.
48. Mitchell, S. H. (2004). Measuring impulsivity and modeling its association with cigarette smoking. Behav. Cogn. Neurosci. Rev. 3, 261-275.
49. Nisell, M., Marcus, M., Nomikos, G. G., and Svensson, T. H. (1997). Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens. J. Neural Transm. 104, 1-10.
50. Nisell, M., Nomikos, G. G., Hertel, P., Panagis, G., and Svensson, T. H. (1996). Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 22, 369-381.
51. Olive, M. E. (2009). Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr. Drug Abuse Rev. 2, 83-98.
52. Olive, M. F., Koenig, H. N., Nannini, M. A., and Hodge, C. W. (2001). Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J. Neurosci. 21, RC184.
53. Olmstead, M. C., Ouagazzal, A. M., and Kieffer, B. L. (2009). Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. Plos OnE 4, e4410. doi:10.1371/journal.pone.0004410
54. Parolaro, D., Rubino, T., Vigano, D., Massi, P., Guidali, C., and Realini, N. (2010). Cellular mechanisms underlying the interaction between cannabinoid and opioid system. Curr. DrugTargets 11, 393-405.
55. Pattij, T., Janssen, M. C., Schepers, I., Gonzalez-Cuevas, G., De Vries, T. J., and Schoffelmeer, A. N. (2007a). Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats. Psychopharmacology (Berl.) 193,85-96.
56. Pattij, T., Janssen, M. C.,Vanderschuren, L. J., Schoffelmeer, A. N., and van Gaalen, M. M. (2007b). Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl.) 191, 587-598.
57. Pattij, T., Schetters, D., Janssen, M. C., Wiskerke, J., and Schoffelmeer, A. N. (2009). Acute effects of morphine on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl.) 205,489-502.
58. Pattij, T., and Vanderschuren, L. J. (2008). The neuropharmacology of impulsive behaviour. Trends Pharmacol. Sci. 29, 192-199.
59. Perry, J. L., and Carroll, M. E. (2008). The role of impulsive behavior in drug abuse. Psychopharmacology (Berl.) 200, 1-26.
60. Pertwee, R. G. (2010). Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr. Med. Chem. 17, 1360-1381.
61. Puumala, T., and Sirvio, J. (1998). Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience 83, 489-499.
62. Ramiro-Fuentes, S., Ortiz, O., Moratalla, R.,andFernandez-Espejo,E. (2010). Intraaccumbens rimonabant is rewarding but induces aversion to cocaine in cocainetreated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors. Neuroscience 167,205-215.
63. Robbins, T. W. (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl.) 163,362-380.
64. Robledo, P., Berrendero, F., Ozaita, A., andMaldonado,R. (2008). Advances in the field of cannabinoid opioid crosstalk. Addict. Biol. 13, 213-224.
65. Rothman, R. B., and Baumann, M. H. (2003). Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479, 23-40.
66. Schad, C. A., Justice, J. B. Jr., and Holtzman, S. G. (2002). Endogenous opioids in dopaminergic cell body regions modulate amphetamineinduced increases in extracellular dopamine levels in the terminal regions.J. Pharmacol Exp. Ther. 300, 932-938.
67. Semenova, S., and Markou, A. (2007). The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task. Neuropharmacology 52,863-872.
68. Serrano, A., and Parsons, L. H. (2011). Endocannabinoid influence in drug reinforcement, dependence and addictionrelated behaviors. Pharmacol. Ther. 132, 215-241.
69. Sesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., and Levey, A. I. (1998). Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18,2697-2708.
70. Solinas, M., Goldberg, S. R., and Piomelli, D. (2008). The endocannabinoid system in brain reward processes. Br. J. Pharmacol. 154, 369-383.
71. Spanagel, R., Herz, A., and Shippenberg, T. S. (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89,2046-2050.
72. Sulzer, D. (2011). How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628-649.
73. Tan da, G., Pontieri, F. E., and Di Chiara, G. (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276,2048-2050.
74. Trezza, V., Baarendse, P. J., and Vanderschuren, L. J. (2010). The pleasures of play: pharmacological insights into social reward mechanisms. Trends Pharmacol. Sci. 31,463-469.
75. Tsutsui-Kimura, I., Ohmura, Y., Izumi, T., Yamaguchi, T., Yoshida, T., and Yoshioka, M. (2010). Nicotine provokes impulsivelike action by stimulating alpha4beta2 nicotinic acetylcholine receptors in the infralimbic, but not in the prelimbic cortex. Psychopharmacology (Berl.) 209,351-359.
76. Tzavara, E. T., Degroot, A., Wade, M. R., Davis, R. J., and Nomikos, G. G. (2009). CB1 receptor knockout mice are hyporesponsive to the behaviorstimulating actions of d-amphetamine: role of mGlu5 receptors. Eur. Neuropsychopharmacol. 19, 196-204.
77. Ungerstedt, U. (1971). Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. Suppl. 367, 1-48.
78. van Gaalen, M. M., Brueggeman, R. J., Bronius, P. F., Schoffelmeer, A. N., and Vanderschuren, L. J. (2006). Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl.) 187, 73-85.
79. Verdejo-Garcia, A., Lawrence, A. J., and Clark, L. (2008). Impulsivity as a vulnerability marker for substanceuse disorders: review of findings from highrisk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev. 32, 777-810.
80. Wang, J. Q., and McGinty, J. F. (1995). Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673, 262-274.
81. Weikop, P., Kehr, J., and Scheel-Kruger, J. (2007). Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors. J. Psychopharmacol. (Oxford) 21, 795-804.
82. Winstanley, C. A. (2011). The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br. J. Pharmacol. 164, 1301-1321.
83. Winstanley, C. A., Eagle, D. M., and Robbins, T. W. (2006). Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev. 26, 379-395.
84. Winstanley, C. A., Olausson, P., Taylor, J. R., and Jentsch, J. D. (2010a). Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol. Clin. Exp. Res. 34, 1306-1318.
85. Winstanley, C. A., Zeeb, F. D., Bedard, A., Fu, K., Lai, B., Steele, C., and Wong, A. C. (2010b). Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the fivechoice serial reaction time task. Behav. Brain Res. 210, 263-272.
86. Wiskerke, J., Schetters, D., van Es, I., van Mourik, Y., den Hollander, B. R., Schoffelmeer, A. N., and Pattij, T. (2011a). mu-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. J. Neurosci. 31, 262-272.
87. Wiskerke, J., Stoop, N., Schetters, D., Schoffelmeer, A. N., and Pattij, T. (2011b). Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice. PLoS ONE 6, e25856. doi:10.1371/journal.pone.0025856
88. Xi, Z. X., Gilbert, J. G., Peng, X. Q., Pak, A. C., Li, X., and Gardner, E. L. (2006). Cannabinoid CB1 receptor antagonist AM251 inhibits cocaineprimed relapse in rats: role of glutamate in the nucleus accumbens. J. Neurosci. 26, 8531-8536.